The Journal of Immunology, Vol 144, Issue 12 4641-4647, Copyright © 1990 by American Association of Immunologists

ARTICLES

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual

AT Profy, PA Salinas, LI Eckler, NM Dunlop, PL Nara and SD Putney
Repligen Corporation, Cambridge, MA 02139.

Sera from individuals infected by HIV-1 usually neutralize multiple viral isolates. To determine the extent to which these neutralizing antibodies recognize a principal neutralizing determinant in the V3 region of the envelope protein gp120 (amino acids 308-332), one broadly neutralizing serum was fractionated by affinity chromatography on immobilized peptide columns. Antibodies that neutralize one isolate (HTLV-IIIMN) were substantially but not completely absorbed by the peptide corresponding to a portion of its V3 determinant, whereas the antibodies that neutralize two other isolates (HTLV-IIIB and HTLV- IIIRF) were not absorbed by homologous peptides corresponding to their neutralizing determinants. Neutralizing antibodies also failed to be absorbed by full length envelope protein gp160 and by two other envelope peptides previously reported to be broadly neutralizing epitopes (amino acids 254-274 and 735-752). We conclude that the infected individual had raised a type-restricted neutralizing response targeted at a linear epitope in the V3 region, and that broad neutralization resulted from recognition of epitopes not yet identified.

This article has been cited by other articles:

				X. Yang, V. Tomov, S. Kurteva, L. Wang, X. Ren, M. K. Gorny, S. Zolla-Pazner, and J. Sodroski Characterization of the Outer Domain of the gp120 Glycoprotein from Human Immunodeficiency Virus Type 1 J. Virol., December 1, 2004; 78(23): 12975 - 12986. [Abstract] [Full Text] [PDF]

				C.-c. Huang, M. Venturi, S. Majeed, M. J. Moore, S. Phogat, M.-Y. Zhang, D. S. Dimitrov, W. A. Hendrickson, J. Robinson, J. Sodroski, et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 PNAS, March 2, 2004; 101(9): 2706 - 2711. [Abstract] [Full Text] [PDF]

				X. Yang, R. Wyatt, and J. Sodroski Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers J. Virol., February 1, 2001; 75(3): 1165 - 1171. [Abstract] [Full Text]

				E. O. Hochleitner, M. K. Gorny, S. Zolla-Pazner, and K. B. Tomer Mass Spectrometric Characterization of a Discontinuous Epitope of the HIV Envelope Protein HIV-gp120 Recognized by the Human Monoclonal Antibody 1331A J. Immunol., April 15, 2000; 164(8): 4156 - 4161. [Abstract] [Full Text] [PDF]

				T. Shiino, K. Kato, N. Kodaka, T. Miyakuni, Y. Takebe, and H. Sato A Group of V3 Sequences from Human Immunodeficiency Virus Type 1 Subtype E Non-Syncytium-Inducing, CCR5-Using Variants Are Resistant to Positive Selection Pressure J. Virol., February 1, 2000; 74(3): 1069 - 1078. [Abstract] [Full Text]

				H. Sato, T. Shiino, N. Kodaka, K. Taniguchi, Y. Tomita, K. Kato, T. Miyakuni, and Y. Takebe Evolution and Biological Characterization of Human Immunodeficiency Virus Type 1 Subtype E gp120 V3 Sequences following Horizontal and Vertical Virus Transmission in a Single Family J. Virol., May 1, 1999; 73(5): 3551 - 3559. [Abstract] [Full Text]

				N. M. Stamatos, J. R. Mascola, V. S. Kalyanaraman, M. K. Louder, L. M. Frampton, D. L. Birx, and T. C. VanCott Neutralizing Antibodies from the Sera of Human Immunodeficiency Virus Type 1-Infected Individuals Bind to Monomeric gp120 and Oligomeric gp140 J. Virol., December 1, 1998; 72(12): 9656 - 9667. [Abstract] [Full Text] [PDF]

				R. Wyatt and J. Sodroski The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens Science, June 19, 1998; 280(5371): 1884 - 1888. [Abstract] [Full Text]

				K. Steimer, C. Scandella, P. Skiles, and N. Haigwood Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120 Science, October 4, 1991; 254(5028): 105 - 108. [Abstract] [PDF]